Trial intelligence / Profile preview

Tranexamic Acid in Total Shoulder Arthroplasty

NCT02569658Completed

Sponsor
Rush University Medical Center
Start
Sep 2015
Primary completion
Apr 2017
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial comparing Tranexamic Acid Group with Placebo Group (2 arms). Primary endpoint: Post-operative Blood Loss at 3 days. Started Sep 2015; status: completed.

02

Drugs

tranexamic acid

Beyond the preview

Go deeper on NCT02569658.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02569658.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call